Letters to the Editor

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation

Department of Data Science, Dana Farber Cancer Institute, Harvard School of Public Health, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Duke Cancer Institute, Duke Medical School, Durham
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Haematologica Early view Aug 26, 2021 https://doi.org/10.3324/haematol.2021.279033